Ajinomoto Valuation Multiples

Discover Ajinomoto's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Kraft Heinz, Foshan Haitian Flavouring, Nestlé India, Lindt and more.

Ajinomoto Overview

About Ajinomoto

Ajinomoto was founded in 1909, and it began manufacturing the world’s first umami seasoning, MSG, made from amino acids. It has since grown to be one of the top manufacturers of sauces and seasonings and has diversified into frozen foods and the manufacture of other amino acid-based materials. Its sauces and seasonings are sold across Southeast Asia, Europe, and the Americas and are found in most supermarkets, making up approximately 60% of its revenue. The remaining 40% is roughly divided into the healthcare and others segment and the frozen food segment. Its healthcare and others segment also includes functional materials, which include an organic resin material, Ajinomoto Build-up Film, which is currently the industry standard for ABF substrates for semiconductors.


Founded

1925

HQ

Japan

Employees

43.4K

Financials (LTM)

Revenue: $10B
EBITDA: $1.8B

EV

$32B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ajinomoto Financials

Ajinomoto reported last 12-month revenue of $10B and EBITDA of $1.8B.

In the same LTM period, Ajinomoto generated $4.1B in gross profit, $1.8B in EBITDA, and $852M in net income.

Revenue (LTM)


Ajinomoto P&L

In the most recent fiscal year, Ajinomoto reported revenue of $10B and EBITDA of $1.8B.

Ajinomoto is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 18%, and net margin of 9%.

See analyst estimates for Ajinomoto
LTMLast FY202320242025202620272028
Revenue$10B$10B$8.8B$9.3B$9.7B
Gross Profit$4.1B$3.7B$3.1B$3.3B$3.6B
Gross Margin40%36%35%36%37%
EBITDA$1.8B$1.8B$1.4B$1.3B$1.3B
EBITDA Margin18%18%16%14%13%
EBIT Margin12%12%10%8%11%
Net Profit$852M$860M$548M$460M$732M
Net Margin8%9%6%5%8%
Net Debt-$1.9B---

Financial data powered by Morningstar, Inc.

Ajinomoto Stock Performance

Ajinomoto has current market cap of $31B, and enterprise value of $32B.

Market Cap Evolution


Ajinomoto's stock price is $31.99.

Ajinomoto share price decreased by 11.8% in the last 30 days, and increased by 26.9% in the last year.

Ajinomoto has an EPS (earnings per share) of $0.90.

See more trading valuation data for Ajinomoto
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$32B$31B-3.3%-11.8%0.7%26.9%$0.90

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ajinomoto Valuation Multiples

Ajinomoto trades at 3.1x EV/Revenue multiple, and 17.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Ajinomoto

EV / Revenue (LTM)


Ajinomoto Financial Valuation Multiples

As of July 18, 2026, Ajinomoto has market cap of $31B and EV of $32B.

Ajinomoto has a P/E ratio of 35.9x.

LTMLast FY202320242025202620272028
EV/Revenue3.1x3.2x3.7x3.5x3.3x
EV/EBITDA17.9x18.0x22.6x24.2x25.0x
EV/EBIT27.1x27.3x36.6x44.9x30.6x
EV/Gross Profit7.8x8.7x10.4x9.6x8.9x
P/E35.9x35.5x55.7x66.4x41.7x
EV/FCF38.4x36.9x62.7x47.4x38.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ajinomoto Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ajinomoto Margins & Growth Rates

Ajinomoto grew revenue by 5% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, Ajinomoto reported gross margin of 36%, EBITDA margin of 18%, and net margin of 9%.

See estimated margins and future growth rates for Ajinomoto

Ajinomoto Margins

Last FY202420252026202720282029
Gross Margin36%36%37%39%
EBITDA Margin18%14%13%16%
EBIT Margin12%8%11%12%
Net Margin9%5%8%8%
FCF Margin9%7%9%8%

Ajinomoto Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%6%4%7%
Gross Profit Growth12%8%8%11%
EBITDA Growth2%(7%)(3%)32%
EBIT Growth7%(19%)47%18%
Net Profit Growth(3%)(16%)59%14%
FCF Growth(13%)32%22%(6%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ajinomoto Operational KPIs

Ajinomoto's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Ajinomoto's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ajinomoto's Rule of X is 34% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ajinomoto
LTMLast FY202320242025202620272028
Rule of 4023%23%---
Bessemer Rule of X31%34%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue14%14%14%14%14%
G&A Expenses to Revenue10%11%10%10%10%
R&D Expenses to Revenue2%2%2%2%2%
Opex to Revenue-25%25%28%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ajinomoto Competitors

Ajinomoto competitors include Kraft Heinz, Foshan Haitian Flavouring, Nestlé India, Lindt, Muyuan Foods, Hershey, Coca-Cola HBC, Yili Group, Church & Dwight and Givaudan.

Most Ajinomoto public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Kraft Heinz1.9x1.9x8.3x8.9x
Foshan Haitian Flavouring6.1x5.9x18.8x19.1x
Nestlé India11.5x11.1x50.1x48.3x
Lindt3.8x3.9x17.9x17.9x
Muyuan Foods1.9x2.1x8.3x10.8x
Hershey3.4x3.3x16.1x14.3x
Coca-Cola HBC1.9x1.8x12.1x11.7x
Yili Group1.8x1.7x10.9x12.0x

This data is available for Pro users. Sign up to see all Ajinomoto competitors and their valuation data.

Start Free Trial

Acquisitions by Ajinomoto

Ajinomoto has acquired 6 companies to date.

Last acquisition by Ajinomoto was on November 13th 2023. Ajinomoto acquired Forge Biologics for $620M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Ajinomoto

Forge Biologics
Granules OmniChem Private Limited
Cambrooke Therapeutics
GeneDesign
Description
Forge Biologics is a Grove City-headquartered gene therapy CDMO founded in 2020. The company offers end-to-end services from plasmid DNA production and viral vector manufacturing to process development and analytical testing. It operates a 64,000-square-foot facility compliant with cGMP standards, partnering with biotech firms to advance AAV, LVV, and LV therapies toward clinical trials.
Granules OmniChem Private Limited is a Hyderabad-headquartered subsidiary of Granules India that manufactures pharmaceutical intermediates and APIs. The facility specializes in high-potency compounds for oncology and cardiovascular drugs, holding approvals from USFDA and EU GMP. Granules OmniChem supplies custom synthesis to global pharma firms from its 150-acre site in Jawaharlal Nehru Pharma City. Established in 2011, it focuses on process development for complex molecules.
Cambrooke Therapeutics is a provider of specialized clinical nutrition products for patients requiring medical dietary therapies. Headquartered in Massachusetts, the company develops formulas for conditions like phenylketonuria, eosinophilic esophagitis, and inflammatory bowel disease. Its products, including EleCare and Neocate brands under license, are prescribed under medical supervision and distributed globally through healthcare providers.
GeneDesign is a Japanese biotechnology company manufacturing oligonucleotides for research and therapeutic applications. Located in Osaka, it synthesizes DNA, RNA, and LNA sequences from micromole to gram scales using automated synthesizers. GeneDesign serves pharmaceutical firms and academic labs with custom primers, probes, and antisense oligos certified for purity.
HQ CountryUnited StatesIndiaUnited StatesJapan
HQ City
Pittsburgh, PA
Visakhapatnam
Fitchburg, MA
Osaka
Deal Date13 Nov 20232 Jun 202010 Nov 20179 Dec 2016
Valuation$620Mundisclosed$64Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ajinomoto acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Ajinomoto

Ajinomoto has invested in 13 companies to date.

Latest investment by Ajinomoto was on June 21st 2026. Ajinomoto invested in NEXT NEW WORLD in their $2M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Ajinomoto

NEXT NEW WORLD
Restore Vision
Somite
Enhanced Medical Nutrition
Description
NEXT NEW WORLD develops and manufactures natural products. It uses sustainable Japanese silk to create apparel and cosmetic goods with low environmental impact.
Restore Vision is a biotechnology company advancing AAV-based gene therapies for retinitis pigmentosa and other inherited retinal diseases. Headquartered in the United States, the firm develops RVI-347 targeting PDE6B mutations to preserve photoreceptor function and slow vision loss.
Somite.ai is a London-based company incorporated in October 2023 developing AI foundation models for stem cell biology. Its AlphaStem platform generates scalable human tissue for therapies addressing diabetes, obesity, muscular dystrophies, with pipeline programs including SMT-M01 for Duchenne muscular dystrophy and SMT-B01 for metabolic disorders.
Enhanced Medical Nutrition is a clinical nutrition company creating medical foods for surgical patients. Its flagship product, PreOp Pro, a powdered drink with whey protein and glutamine, shortens recovery time by 20 percent post-colorectal surgery, while PostOp Pro supports gut healing. Launched in 2022 in Boston, Massachusetts, EMN partners with hospitals like Massachusetts General and distributes through McKesson, reaching 200 facilities nationwide within its first year.
HQ CountryJapanJapanUnited StatesCanada
HQ City
Kiryu
Tokyo
Boston, MA
Toronto
Deal Date21 Jun 202614 Apr 202613 May 202514 Jan 2025
RoundSeries ASeries BSeries ASeries A
Raised$2M$8M$47M$5M
Investors15th Rock; S. T.Corp; Mizuho Capital; integrate; Ajinomoto; Pola Orbis Holdings; Shinkin CapitalShionogi; Nippon Venture Capital; JIC Venture Growth Investments; Ajinomoto; Japan Science and Technology Agency; Astellas Venture Management; Kyoto University Innovation Capital; Remiges Ventures; Higin CapitalPitango VC; Fidji Simo; SciFi VC; Chan Zuckerberg Initiative; R. Martin Chavez; Khosla Ventures; Ajinomoto; TechAviv; Fusion Fund; HarpoonDSM-Firmenich Venturing; PeakBridge; Ajinomoto; Elder Ventures
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ajinomoto investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ajinomoto

When was Ajinomoto founded?Ajinomoto was founded in 1925.
Where is Ajinomoto headquartered?Ajinomoto is headquartered in Japan.
How many employees does Ajinomoto have?As of today, Ajinomoto has over 43K employees.
Who is the CEO of Ajinomoto?Ajinomoto's CEO is Shigeo Nakamura.
Is Ajinomoto publicly listed?Yes, Ajinomoto is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Ajinomoto?Ajinomoto trades under 2802 ticker.
When did Ajinomoto go public?Ajinomoto went public in 1949.
Who are competitors of Ajinomoto?Ajinomoto main competitors include Kraft Heinz, Foshan Haitian Flavouring, Nestlé India, Lindt, Muyuan Foods, Hershey, Coca-Cola HBC, Yili Group, Church & Dwight, Givaudan.
What is the current market cap of Ajinomoto?Ajinomoto's current market cap is $31B.
What is the current revenue of Ajinomoto?Ajinomoto's last 12 months revenue is $10B.
What is the current revenue growth of Ajinomoto?Ajinomoto revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Ajinomoto?Current revenue multiple of Ajinomoto is 3.1x.
What is the current EBITDA of Ajinomoto?Ajinomoto's last 12 months EBITDA is $1.8B.
What is Ajinomoto's EBITDA margin?Ajinomoto's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Ajinomoto?Current EBITDA multiple of Ajinomoto is 17.9x.
What is the current FCF of Ajinomoto?Ajinomoto's last 12 months FCF is $838M.
What is Ajinomoto's FCF margin?Ajinomoto's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Ajinomoto?Current FCF multiple of Ajinomoto is 38.4x.
How many companies Ajinomoto has acquired to date?As of July 2026, Ajinomoto has acquired 6 companies.
What was the largest acquisition by Ajinomoto?$800M acquisition of Windsor Foods on 10th September 2014 was the largest M&A Ajinomoto has done to date.
What companies Ajinomoto acquired?Ajinomoto acquired Windsor Foods, Forge Biologics, Orgen, Cambrooke Therapeutics, GeneDesign, and Granules OmniChem Private Limited.
In how many companies Ajinomoto has invested to date?As of July 2026, Ajinomoto has invested in 13 companies.
What was the last Ajinomoto investment?On 21st June 2026 Ajinomoto invested in NEXT NEW WORLD, participating in a $2M Series A round, alongside 15th Rock, S. T.Corp, Mizuho Capital, integrate, Pola Orbis Holdings, and Shinkin Capital.
In what companies Ajinomoto invested in?Ajinomoto invested in Promasidor, Ascend Gene & Cell Therapies, Somite, Tsubame BHB, TechMagic, Hinoman, IPS Portal, Restore Vision, Safire Technology Group, On The Slope, Enhanced Medical Nutrition, SARAH, and NEXT NEW WORLD.

See public comps similar to Ajinomoto

Lists including Ajinomoto

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial